WASHINGTON (AP) — U.S. officials on Monday approved the first long-acting drug to protect babies and toddlers against a respiratory virus that sends tens of thousands of American children to the hospital each year.
RSV is a cold-like nuisance for most healthy people, but it can be life-threatening in the very young and the elderly.
The Food and Drug Administration approved the injection for infants and children up to 2 years old who face increased risk of severe RSV.
2026 Arkansas Farm Families of the Year
One of Boone County's Most Wanted Has Missouri Connection
Missouri Department of Public Safety to Move Notification System In-House
Harrison 150 Celebration Underway
UA Northark Finalizes Degree Program with UAM